Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression.
about
Psychomotor retardation in depression: biological underpinnings, measurement, and treatmentDuloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic featuresOpen questions in current models of antidepressant action.Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms.
P2860
Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression.
@ast
Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression.
@en
Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression.
@nl
type
label
Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression.
@ast
Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression.
@en
Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression.
@nl
prefLabel
Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression.
@ast
Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression.
@en
Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression.
@nl
P2860
P1476
Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression.
@en
P2093
J D Amsterdam
P2860
P304
P356
10.1177/0269881198012003061
P407
P433
P577
1998-01-01T00:00:00Z